HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
OPKO Health, Inc. (OPK)
4.02  0  (0%) 07-13 02:54
Open: 3.96 High: 4.14
Pre.close: 4.02 Low: 3.91
Volume: 9,606,874 Ave vol: 14,161,277
52w High: 4.27 52w Low: 1.12
MA(50): 2.812 MA(200): 1.992
EPS: -0.483 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.opko.com
Market Cap (M): 2,693
Shares Out (M): 670
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 4.99 Target 2: 5.83
Resist 1: 4.27 Resist 2: 4.99
Support 1: 3.03 Support 2: 2.27
Company key metrics
Revenue per Share: 1.5147
Net Income per Share: -0.5289
Cash per Share: 0.1435
Book Value per Share: 2.7118
Price to Sales: 0.9771
Price to Book Value: 0.5458
Earnings Yield: -0.3574
Dividend Yield: 0
Debt to Equity: 0.4301
Debt to Assets: 0.3007
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Thu, 09 Jul 2020
Why OPKO Health (OPK) Stock Might be a Great Pick - Yahoo Finance

Fri, 10 Jul 2020
OPKO Health (OPK) Flat As Market Gains: What You Should Know - Yahoo Finance

Tue, 30 Jun 2020
Were Hedge Funds Right About Souring On Opko Health Inc. (OPK)? - Yahoo Finance

Mon, 06 Jul 2020
Here's Why You Should Invest in OPKO Health (OPK) Stock Now - Yahoo Finance

Thu, 25 Jun 2020
OPKO Health, Inc. (OPK) CEO Phillip Frost Hosts 2020 Annual Meeting of Stockholders (Transcript) - Seeking Alpha

Tue, 07 Jul 2020
OPKO Health Inc. (OPK) is set for a tempting yields with an average volume of 14.00M - The InvestChronicle

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.